A novel machine learning-based algorithm can predict individualized risk of death and complications after PCI, as demonstrated in a new analysis. The Blue Cross Blue Shield of Michigan Cardiovascular ...

Currently, the primary efficacy measures for antidepressant clinical trials predominantly assess changes in mood symptoms in patients with major depressive disorder (MDD). When considering treatment ...

In this article, we argue in favor of a promising paradigm for training physicians: competency-based medical education (CBME). 10 CBME takes an outcomes-based approach in training learners to become ...

Critical Path Institute's (C-Path) Patient-Reported Outcome (PRO) Consortium announces U.S. Food and Drug Administration (FDA) qualification of two new clinical outcome assessment tools: the Asthma ...